Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Edelweiss | HDFC |
| NAV | ₹36.4592 | ₹23.6750 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 8.7 years | 3.1 years |
| Expense ratio | 1.4% | 1.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 45.20 | 94.50 |
Returns
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | +5.92% | +12.97% |
| 3 months | +2.40% | +7.13% |
| 6 months | +20.35% | +17.84% |
| YTD | +25.20% | +33.73% |
| 1 year | +23.75% | +32.20% |
| 3 years (CAGR) | +17.13% | +30.70% |
| 5 years (CAGR) | +11.04% | — |
| 10 years (CAGR) | — | — |
| Since launch | +15.95% | +31.83% |
Risk
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 20.9% | 15.8% |
| Downside volatility | 12.9% | 8.5% |
| Sharpe | 0.51 | 1.53 |
| Sortino | 0.82 | 2.86 |
| Calmar | 0.69 | 2.06 |
| Return / risk | 0.82 | 1.95 |
| Deepest fall | −32.34% | −14.91% |
| Days to recover | 155 | 126 |
| Below its high | −1.63% | +0.00% |
Against benchmark
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | +5.69% | +7.54% |
| Beta | 0.97 | 0.97 |
| R² | 56.3% | 85.0% |
| Up capture | 114.2% | 108.9% |
| Down capture | 93.5% | 71.0% |
| Tracking error | 13.8% | 6.1% |
| Information ratio | 0.40 | 1.17 |
| Treynor | 0.10 | 0.24 |
Consistency
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +98.01% | +67.01% |
| Middle 1-year | +17.30% | +23.25% |
| Worst 1-year | −23.25% | +1.71% |
| 1-year periods with a loss | 23.7% | 0.0% |
| Middle 3-year | +18.97% | +30.22% |
| Positive months | 66.7% | 72.2% |
| Best day | +3.68% | +3.18% |
| Worst day | −5.79% | −3.61% |
| Worst 5% day | −1.93% | −1.51% |
| Positive days | 57.6% | 58.3% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | +17.87% | — |
| 5-year value | ₹9,45,521 | — |
| 3-year XIRR | +18.35% | +27.71% |
| 1-year XIRR | +35.31% | +41.37% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.